Gates Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-906,256
Closed -$70.9M 35
2024
Q4
$70.9M Sell
906,256
-25,000
-3% -$2.13M 1.33% 28
2024
Q3
$87.4M Sell
931,256
-499,310
-35% -$41.9M 1.53% 25
2024
Q2
$111M Sell
1,430,566
-212,806
-13% -$17.4M 2.21% 20
2024
Q1
$149M Sell
1,643,372
-51,800
-3% -$4.31M 3.11% 10
2023
Q4
$131M Sell
1,695,172
-1,013,663
-37% -$71M 3.02% 12
2023
Q3
$184M Buy
2,708,835
+402,900
+17% +$29.3M 4.61% 5
2023
Q2
$187M Buy
2,305,935
+113,614
+5% +$9.07M 4.41% 4
2023
Q1
$180M Buy
2,192,321
+1,437,341
+190% +$103M 4.78% 5
2022
Q4
$44.1M Buy
+754,980
New +$43.5M 1.39% 27

Other funds holding GEHC

Gates Capital Management's GEHC Position: Q1 2025 in Review

Gates Capital Management sold out of GE HealthCare (GEHC) in Q1 2025, closing a stake of 906,256 shares — an estimated $70.9M sold.

Gates Capital Management first reported a position in GEHC in Q4 2022 and held it in 9 quarters. The position peaked at $187M in Q2 2023. 1,368 funds tracked by Wall St. Rank hold GEHC as of Q1 2025.

  • Gates Capital Management reported no remaining GE HealthCare position as of Q1 2025 after selling out during the quarter.
  • Gates Capital Management sold 906,256 GE HealthCare shares in Q1 2025, an estimated $70.9M.
  • Gates Capital Management first reported a position in GE HealthCare in Q4 2022 and held it in 9 quarters.
  • Gates Capital Management's GE HealthCare position peaked at $187M in Q2 2023.
  • 1,368 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2025.

Based on Gates Capital Management's 13F filing for Q1 2025, filed 15 May 2025.